126 related articles for article (PubMed ID: 15160922)
1. The effect of tetraethylenepentamine, a synthetic copper chelating polyamine, on expression of CD34 and CD38 antigens on normal and leukemic hematopoietic cells.
Prus E; Peled T; Fibach E
Leuk Lymphoma; 2004 Mar; 45(3):583-9. PubMed ID: 15160922
[TBL] [Abstract][Full Text] [Related]
2. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice.
Peled T; Landau E; Mandel J; Glukhman E; Goudsmid NR; Nagler A; Fibach E
Exp Hematol; 2004 Jun; 32(6):547-55. PubMed ID: 15183895
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid receptor antagonist inhibits CD38 antigen expression on human hematopoietic cells in vitro.
Prus E; Chandraratna RA; Fibach E
Leuk Lymphoma; 2004 May; 45(5):1025-35. PubMed ID: 15291363
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
[TBL] [Abstract][Full Text] [Related]
6. The effect of the copper chelator tetraethylenepentamine on reactive oxygen species generation by human hematopoietic progenitor cells.
Prus E; Fibach E
Stem Cells Dev; 2007 Dec; 16(6):1053-6. PubMed ID: 18047399
[TBL] [Abstract][Full Text] [Related]
7. Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.
Kawakami M; Kimura T; Kishimoto Y; Tatekawa T; Baba Y; Nishizaki T; Matsuzaki N; Taniguchi Y; Yoshihara S; Ikegame K; Shirakata T; Nishida S; Masuda T; Hosen N; Tsuboi A; Oji Y; Oka Y; Ogawa H; Sonoda Y; Sugiyama H; Kawase I; Soma T
Leukemia; 2004 May; 18(5):912-21. PubMed ID: 14999295
[TBL] [Abstract][Full Text] [Related]
8. CD34+CD38- is a good predictive marker of cloning ability and expansion potential of CD34+ cord blood cells.
Encabo A; Mateu E; Carbonell-Uberos F; Miñana MD
Transfusion; 2003 Mar; 43(3):383-9. PubMed ID: 12675725
[TBL] [Abstract][Full Text] [Related]
9. CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood.
Sovalat H; Racadot E; Ojeda M; Lewandowski H; Chabouté V; Hénon P
J Hematother Stem Cell Res; 2003 Oct; 12(5):473-89. PubMed ID: 14594504
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells.
Liu H; Verfaillie CM
Exp Hematol; 2002 Jun; 30(6):582-9. PubMed ID: 12063025
[TBL] [Abstract][Full Text] [Related]
11. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
12. Karyotyping, immunophenotyping, and apoptosis analyses on human hematopoietic precursor cells derived from umbilical cord blood following long-term ex vivo expansion.
Tian H; Huang S; Gong F; Tian L; Chen Z
Cancer Genet Cytogenet; 2005 Feb; 157(1):33-6. PubMed ID: 15676144
[TBL] [Abstract][Full Text] [Related]
13. Loss of CD38 antigen on CD34+CD38+ cells during short-term culture.
von Laer D; Corovic A; Vogt B; Fehse B; Roscher S; Rimek A; Baum C; Ostertag W
Leukemia; 2000 May; 14(5):947-8. PubMed ID: 10803533
[No Abstract] [Full Text] [Related]
14. Functional cloning of IGFBP-3 from human microvascular endothelial cells reveals its novel role in promoting proliferation of primitive CD34+CD38- hematopoietic cells in vitro.
Liu LQ; Sposato M; Liu HY; Vaudrain T; Shi MJ; Rider K; Stevens Z; Visser J; Deng HK; Kraus M
Oncol Res; 2003; 13(6-10):359-71. PubMed ID: 12725526
[TBL] [Abstract][Full Text] [Related]
15. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
Xiao M; Oppenlander BK; Plunkett JM; Dooley DC
Exp Hematol; 1999 May; 27(5):916-27. PubMed ID: 10340408
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of umbilical cord blood hematopoietic progenitor cells by combinations of cytokines.
Urashima M; Hoshi Y; Akiyama M; Kamijo M; Kato Y; Akatsuka J; Maekawa K; Matsuzaki M; Ohnishi J; Kaihara C
Acta Paediatr Jpn; 1995 Apr; 37(2):160-5. PubMed ID: 7540792
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of normal and CML CD34-positive cells: only the most primitive CML progenitors include Ph-neg cells.
De Fabritiis P; Dowding C; Bungey J; Chase A; Angus G; Szydlo R; Goldman JM
Leuk Lymphoma; 1993 Sep; 11(1-2):51-61. PubMed ID: 7693107
[TBL] [Abstract][Full Text] [Related]
18. During ontogeny primitive (CD34(+)CD38(-)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts.
Oh IH; Lau A; Eaves CJ
Blood; 2000 Dec; 96(13):4160-8. PubMed ID: 11110687
[TBL] [Abstract][Full Text] [Related]
19. CD38 ligation inhibits normal and leukemic myelopoiesis.
Todisco E; Suzuki T; Srivannaboon K; Coustan-Smith E; Raimondi SC; Behm FG; Kitanaka A; Campana D
Blood; 2000 Jan; 95(2):535-42. PubMed ID: 10627459
[TBL] [Abstract][Full Text] [Related]
20. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells.
Peled T; Glukhman E; Hasson N; Adi S; Assor H; Yudin D; Landor C; Mandel J; Landau E; Prus E; Nagler A; Fibach E
Exp Hematol; 2005 Oct; 33(10):1092-100. PubMed ID: 16219531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
